These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 2549539)
21. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717 [TBL] [Abstract][Full Text] [Related]
22. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Schaefer BC; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841 [TBL] [Abstract][Full Text] [Related]
23. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity. Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944 [TBL] [Abstract][Full Text] [Related]
24. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005 [TBL] [Abstract][Full Text] [Related]
25. The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R. Buisson M; Manet E; Trescol-Biemont MC; Gruffat H; Durand B; Sergeant A J Virol; 1989 Dec; 63(12):5276-84. PubMed ID: 2555554 [TBL] [Abstract][Full Text] [Related]
26. Novel 12-O-tetradecanoylphorbol-13-acetate-responsive elements in the upstream sequence of the MS gene promoter of Epstein-Barr virus. Liu QY; Summers WC J Virol; 1989 Dec; 63(12):5062-8. PubMed ID: 2555542 [TBL] [Abstract][Full Text] [Related]
27. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines. Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516 [TBL] [Abstract][Full Text] [Related]
28. Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation. Nonkwelo CB; Long WK Virology; 1993 Nov; 197(1):205-15. PubMed ID: 8212555 [TBL] [Abstract][Full Text] [Related]
30. Identification of an enhancer-type sequence that is responsive to Z and R trans-activators of Epstein-Barr virus. Shimizu N; Sakuma S; Ono Y; Takada K Virology; 1989 Oct; 172(2):655-8. PubMed ID: 2552665 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Fåhraeus R; Jansson A; Ricksten A; Sjöblom A; Rymo L Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7390-4. PubMed ID: 2170976 [TBL] [Abstract][Full Text] [Related]
32. Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression. Oguro MO; Shimizu N; Ono Y; Takada K J Virol; 1987 Oct; 61(10):3310-3. PubMed ID: 3041051 [TBL] [Abstract][Full Text] [Related]
34. Evidence for a functional glucocorticoid responsive element in the Epstein-Barr virus genome. Schuster C; Chasserot-Golaz S; Urier G; Beck G; Sergeant A Mol Endocrinol; 1991 Feb; 5(2):267-72. PubMed ID: 1645455 [TBL] [Abstract][Full Text] [Related]
35. Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter. Swaminathan S Virology; 1996 Mar; 217(2):532-41. PubMed ID: 8610445 [TBL] [Abstract][Full Text] [Related]
36. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1. Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783 [TBL] [Abstract][Full Text] [Related]
37. A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes. Petti L; Sample J; Wang F; Kieff E J Virol; 1988 Apr; 62(4):1330-8. PubMed ID: 2831394 [TBL] [Abstract][Full Text] [Related]
38. Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus. Salamon D; Takacs M; Ujvari D; Uhlig J; Wolf H; Minarovits J; Niller HH J Virol; 2001 Mar; 75(6):2584-96. PubMed ID: 11222681 [TBL] [Abstract][Full Text] [Related]
39. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region. Marquitz AR; Mathur A; Edwards RH; Raab-Traub N J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882 [TBL] [Abstract][Full Text] [Related]
40. Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells. Ricksten A; Svensson C; Welinder C; Rymo L J Gen Virol; 1987 Sep; 68 ( Pt 9)():2407-18. PubMed ID: 2821180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]